Skip to main content
Erschienen in: BMC Nephrology 1/2021

Open Access 01.12.2021 | Research

Is health-related quality of life associated with adequacy of hemodialysis in chronic kidney disease patients?

verfasst von: Lamia M. Hasan, Dina A. H. Shaheen, Ghada A. H. El Kannishy, Nagy A. H. Sayed-Ahmed, Ahmed M. Abd El Wahab

Erschienen in: BMC Nephrology | Ausgabe 1/2021

Abstract

Introduction

Monitoring Health Related Quality of Life (HRQoL) in different stages of chronic kidney disease is advised by all nephrology societies. We aimed to study the relation between quality of life and dialysis adequacy.

Methods

One hundred patients (51% males), on regular hemodialysis 3/week for > 6 months in two hospitals were included. Single pool Kt/V was used to assess dialysis adequacy. Patients were grouped into 3 divisions according to Kt/v: Group A > 1.5 (n = 24), group B 1.2–1.5 (n = 54) and group C < 1.2 (n = 22). KDQOL-SF™ questionnaire was used to study quality of life in our groups. Group C was reassessed after 3 months of improving Kt/v.

Results

Mean values were: Kt/V (1.48 ± 0.41), Cognitive Function (84.27 ± 9.96), Work status (30.00 ± 33.33), Energy (45.70 ± 13.89), Physical Function and Role limitations due to physical function (45.30 ± 12.39 and 31.25 ± 19.26, respectively). Group A had significantly higher scores of KDQOL-SF except Role limitations due to Physical Function. All subscales improved in group C after Kt/v improvement except 3 subscales, namely, work status, patient satisfaction and role limitation due to physical and emotional functions.

Conclusion

Inadequate HD badly affects quality of life and improving adequacy refines many components of quality of life.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

End stage renal disease (ESRD) is an increasing issue worldwide impairing patients Qol [1]. Hemodialysis (HD) is the mostly used for treatment [2] leading to overt changes in patients’ lives [3, 4].
Improving dialysis adequacy, anemia, hyperparathyroidism and many other factors is known to lessen morbidity and mortality in dialysis patients [58].
Dialysis adequacy evaluation is difficult as many factors like volume status, electrolytes and acid base interfere with it but Kt/v is the mostly used parameter.
The reported prevalence of ESRD in Egypt is estimated to be 624 pmp [9].
Many physicians looking after hemodialysis patients are interested mainly in the clinical and laboratory data of their patients, paying little attention to the patients’ emotional satisfaction and their quality of life.
Most of regular HD patients are vulnerable for many physical and psychological disabilities like easy fatigability, myalgia, depression and sexual dysfunction [10].
Many disease-specific questionnaires such as the World Health Organization Quality of Life Survey (WHOQoL), Short Form (SF)-36 health questionnaire and the Choices Health Experiences Questionnaire [CHEQ] are used to assess HRQoL in ESRD [11].
Of the 36 items in the SF-36 questionnaire, we only used 35 items representing 2 summary measures, the physical component summary (PCS), mental component summary (MCS) and 8 scales [12].
Advantages of KDQOL-SF are: 1) Tested in different populations with renal disease. 2) It includes general and specific modules evaluating chronic kidney disease. 3) Effective in hemodialysis and peritoneal dialysis patients’ assessment. 4) It can be self-applied or applied by an interviewer. 5) It has been culturally adapted and validated in various languages [13].
This work was planned to focus on assessing HRQOL among ESRD patients treated with hemodialysis in relation to different variables, especially the adequacy of dialysis relying on the calculated kt/V.

Patients and methods

Study

This study was conducted in Mansoura Nephrology and Dialysis Unit (MNDU) and Talkha hemodialysis units from 2017 to 2018.
Criteria of inclusion:
  • Gender: Both
  • Age: Older than 20 years
  • Maintained on HD (thrice weekly) for ≥6 months.
  • Patients with controlled DM or hypertension (HTN) (Uncontrolled blood pressure > 150/90 in average weekly predialysis reading while the patient is on maximum doses of 3 or more antihypertensive medications with ideal dry body weight. Uncontrolled DM means FPG > 130 and PPG > 150 in average weekly reading using bedside glucose measuring devices).
The exclusion criteria included:
  • Recently dialyzed patients (less than 6 months)
  • Patients with cognitive impairment
  • Patients with mental retardation
  • Patients with COPD
  • Patients with severe anaemia
  • Patient with uncontrolled DM or HTN
  • Patients with other system failure
The study was approved by our faculty IRB, The nature and intent of the study were fully explained to all subjects, and an informed written consent was obtained from each participant before running the study.
One hundred thirty-four patients were screened and 119 patients met the inclusion criteria. One hundred patients out of 119 agreed to participate.
All patients were being subjected to history taking and full examination.

Study design

The 100 subjects who agreed to participate in this study were divided according to their kt/v into three groups:
  • The first group (group A) with kt/v > 1.5 (n = 24).
  • The second group (group B) with kt/v range from [1.5–1.2] (n = 54).
  • The third group (group c) with kt/v < 1.2 (n = 22).
Measures to improve kt/v were applied to Group C and then all the collected parameters were tested again in this group.
Improving kt/v is done for group C for 3 months through:
1.
Adjustment of dialyser surface area
 
2.
Increasing blood flow rates.
 
3.
Extending session time.
 

Anthropometric measurements

The patients’ weight in kilograms before and after dialysis sessions, dialysis session duration, ultrafiltration volume, was collected for all patients.

Specimen collection

Pre-dialysis blood samples were withdrawn into 2 vaccutainer tubes from all subjects at the start of the study and after 3 months for group C. Both predialysis and postdialysis urea samples were withdrawn before and after the same session of HD. Daugirdas et al. [14] formula was used for Calculation of Kt/V:
Kt/V = −ln (Ratio-0.03) + [(4-(3.5 × Ratio)) × (UF/Wt)], in which Ratio is post BUN/pre BUN, UF is ultrafiltration volume, and Wt is post dialysis weight.
Biochemical analysis:
  • Complete blood count, Liver function tests, serum calcium, serum phosphorus and iPTH were measured.

Subjective methods

HRQOL was assessed with the validated Kidney Disease Quality of Life-Short Form (KDQOL-SF version 1.3): http://​gim.​med.​ucla.​edu/​kdqol/​downloads/​-download.​html [15].
KDQOL-SF 36 issued by Hays et al. in 1994 and is published for free on internet website: http://​gim.​med.​ucla.​edu/​kdqol/​downloads-download.​html.
For purpose of simplicity, the KDQOL-SF version 1.3 was summarized in three categories; namely, kidney disease targeted scales, physical component and mental component summaries, each of which drives its core information and calculations from one or a group of questions from the original 36 questions. The user manual of this questionnaire with these details was previously published [16].
The KDQOL-SF can be split in a generic part and a disease-specific part. First, the generic part is formed by the SF-36 version 1. The domains of the SF-36 can be summarized in two summary scores, one for physical functioning (physical component summary—PCS) and one for mental functioning (mental component summary—MCS). These summaries are constructed so that a score of 50 represents the mean of the general United States population with a standard deviation of 10 [16]. Second, the disease-specific part of the KDQOL-SF consists of 44 kidney disease-targeted questions. The responses to these items are condensed in 12 domains. These domains have a score from 0 to 100, with higher scores indicating the absence of problems.
Results from the SF-36 instrument are further summarized into a physical composite summary (PCS) score and a mental composite summary (MCS) score. PCS aggregates items from physical function, role physical, pain, vitality and general health. MCS aggregates items from role emotional, emotional wellbeing, energy, social function and general health. These summaries are constructed so that a score of 50 represents the mean of the general United States population with a standard deviation of 10 [16].
There are some explanations to some questionnaire items:
1.
Physical functioning (PF) – the level of limitation of physical activity caused by health limitations
 
2.
Role physical (RP) – helps measure the limitations of patient-specific physical activity caused by health problems
 
3.
Vitality (VT) – measurement of energy and fatigue
 
4.
Social functioning (SF) – defines the level of social life limitations caused by physical and emotional discomfort
 
5.
Mental health (MH)– defines the level of psychological stress and well-being [17].
 
A previous study, carried out in Alexandria, Egypt [18], utilized an Arabic translation of the KDQOL-SF version 1.3 and the authors concluded that this translation is a validated and reliable tool for studying the HRQOL in ESRD patients. In the current study, this Arabic version of KDQOL-SF1.3 was also used for assessment of HRQOL with some additional section translated from the original English version to suit the patients on regular hemodialysis. The questionnaire was used to assess the studied population and to group C before and after improving kt/v. One item studying sexual activity in the KDQOL-SF™ was excluded from the study as nearly all patients refused to talk about that issue (cultural concerns).

Scoring system

The standard scoring program of the KDQOL-SF™ 1.3 is based on the Microsoft Excel 97 spreadsheet program and includes information about the computation method:
The scores for each dimension range from 0 to 100, with higher scores reflecting better HRQOL. The change in health (question 2) of the SF36 scale and the 0–10 overall health rating (question 22) items are scored as single items [13].

Statistical methods

Data were tabulated, coded then analyzed using the computer program SPSS (Statistical package for social science) version 20.0 to obtain.
Descriptive data:
Descriptive statistics were calculated in the form of:
1.
Mean ± Standard deviation (SD).
 
2.
Median & interquartile range (IQR) [25, 75].
 
3.
Frequency (Number-percent).
 

Analytical statistics

  • In the statistical comparison between the different groups the normality of distribution in continuous data was checked by kolmogorov-smirnov test, and Shapiro-Wilk normality test
  • The significance of difference in groups (A, B, C) was tested using Kruscalwalis’ H test
  • The comparison between the three groups was done using Bonferroni post-hoc test. The level of significance was set at p <  0.05.
  • Measurements within the same group C before and after improving, were statistically compared using paired t-test or Wilcoxon signed-ranks test for parametric or non-parametric data, respectively. Results are presented as counts for nominal variables, and as mean ± standard deviation (SD) and median (interquartile range) for continuous variables. The level of significance was set at p <  0.05.

Results

This study involved 100 HD patients with an age ranging between 28 and 62 years (mean 48.8 ± 5.89 years). DM was present in 26% of the patients while HTN was present in 82%. HTN was the cause of ESRD in 58% of the patients while DM was the cause in 22% (Table 1). It included 51 males and 49 females with their weights ranging between 54 and 104 Kg (mean 79.01 ± 11.35 Kg). All the patients were treated with regular HD sessions three times weekly with a median (IQR) duration of 4 h and the interdialytic weight gain ranging between 1 and 4 kg (mean2.60 ± 0.96) per session. The mean kt/v was 1.48 ± 41. As regard the KDQOL_SF v 1.3 scoring system, the mean of the scores of the item related to “Symptoms and Problem” list of the total studied population was 71.29 ± 17.27; a figure that is not far from a maximum possible score of 100 for the least symptoms and problems. The mean of the scores of the item dealing with “Effect of kidney disease” was also reasonable, 65.13 ± 11.03. On the other hand, the mean of the scores of the item dealing with “Work status”, “Energy”, “Physical Function” as well as “Role limitations due to physical function” were very low (30.00 ± 33.33, 45.70 ± 13.89, 45.30 ± 12.39 and 31.25 ± 19.26; respectively), while the mean of the scores of the item referring to “Cognitive Function” was high [mean 84.27 with SD 9.96] (Table 2). Twenty four patients of the studied population had kt/v > 1.5 (group A), 54 patients had kt/v between (1.2 and 1.5; group B) and 22 had Kt/v < 1.2 (group C). The studied general and laboratory variables of the three Kt/v groups (Table 3) were comparable regarding age, pre-dialysis urea and albumin. However, the body weights before sessions were significantly higher in group (A). There was also a highly significant difference between the interdialytic weight gain and session durations between the three groups with the greatest volumes and longest sessions in group (A). On the other hand, calcium and hemoglobin were significantly higher in group A, while PTH and phosphorus were significantly higher in group C versus other groups (Table 3). Regarding the KDQOL-SF V 1.3 questionnaire, the comparison of the scores of the items between the three studied groups, showed highly significant differences between the three groups except for 2 subscales; the “Role limitations due to Physical and emotional function” (Table 4).
Table 1
General descriptive characteristics of the total studied patients (n = 100)
Age (Year, Mean ± SD)
48.8 ± 5.89
DM (N, %)
26 (26%)
HTN (N, %)
82 (82%)
Original kidney disease
• HTN (N, %)
58 (58%)
• DM (N, %)
22 (22%)
• Stones, pyelonephritis
12 (12%)
• Undetermined
8 (8%)
Table 2
Descriptives of the response to the questionnaire of the total studied patients (n = 100)
Questionnaire’s items
Mean ± SD
Median (IQR)
Symptoms / problems list
71.29 ± 17.27
77.08 (70.83–81.25)
Effect of kidney disease
65.13 ± 11.03
65.63 (95.37–71.87)
Burden of kidney disease
55.75 ± 15.78
62.50 (50–68.75)
Work Status
30.00 ± 33.33
25 (0.00–50.00)
Cognitive function
84.27 ± 9.96
86.67 (80.00–93.33))
Quality of Social interaction
64.27 ± 14.63
66.67 (53.33–73.33)
Sleep
64.25 ± 18.34
70 (58.13–75)
Overall health
65.50 ± 20.76
70.00 (70–80)
Patient satisfaction
44.33 ± 11.42
50.00 (33.33–50)
Physical function
45.30 ± 12.39
45.00 (35.0–53.75)
Role limitation due to physical function
31.25 ± 19.26
25.00 (25.0–50)
Pain
49.90 ± 20.67
55.00 (36.87–67.50)
General health
52.40 ± 11.84
50.00 (45–60)
Emotional Well Being
61.36 ± 14.17
68.00 (56.00–72)
Role limitations due to emotional problems
52.67 ± 28.10
66.67 (33.33–66.66)
Social function
54.20 ± 21.84
62.5(50.00–75.00)
Energy
45.70 ± 13.89
50.00 (40.00–55.00))
Physical composite
36.60 ± 5.51
36.70 (32.47–40.20)
Mental composite
42.11 ± 9.11
45.20 (36.11–48.23)
Table 3
Comparison between the three groups of patient regarding the general data (n = 100)
  
Group A
Group B
Group C
P value.
Group A vs Group B
Group A vs Group C
Group B vs Group C
Age (Year)
N
24
54
22
0.636
   
Mean
50.45 ± 1.77
49.89 ± 2.38
50.64 ± 3.84
Mean Ranks
53.79
47.98
53.09
Pre-urea (mg/dl)
N
24
54
22
0.206
   
Mean
120.33 ± 28.80
129.93 ± 26.35
129.00 ± 35.17
Mean Ranks
41.44
53.94
51.95
Pre session weight (Kg)
N
24
54
22
0.042
0.036
0.389
1.000
Mean
83.48 ± 10.54
76.99 ± 11.10
79.09 ± 13.99
Mean Ranks
62.98
45.11
50.11
Interdialytic weight gain (Kg)
N
24
54
22
0.002
1.000
0.006
0.003
Mean
2.35 ± 1.03
2.42 ± 0 .95
3.20 ± 0.59
Mean Ranks
43.44
45.90
69.50
Dialysis session time (hrs)
N
24
54
22
< 0.0001
0.938
< 0.0001
< 0.0001
Mean
4.00 ± 0.00
3.89 ± 0.32
3.05 ± 0.043
Mean Ranks
63.50
58.00
17.91
Serum calcium (mg/dl)
N
24
54
22
0.001
0.010
0.001
0.568
Mean
9.84 ± 0.83
9.22 ± 0.79
8.93 ± 0.88
Mean Ranks
68.50
47.59
38.00
Serum Ph (mg/dl)
N
24
54
21
0.007
1.000
0.013
0.015
Mean
4.65 ± 0.57
4.68 ± 1.08
5.38 ± 0.77
Mean Ranks
42.73
46.56
67.17
Serum albumin (g/dl)
N
24
54
22
0.704
   
Mean
3.35 ± 0.40
3.27 ± 0.39
3.28 ± 0.46
Mean Ranks
54.79
49.00
49.50
Serum PTH (pg/ml)
N
24
53
22
< 0.0001
0.480
< 0.0001
< 0.0001
Mean
158.10 ± 150.73
318.89 ± 486.23
750.00 ± 523.20
Mean Ranks
35.25
45.18
77.70
Hb (g/dl)
N
24
54
22
< 0.0001
0.012
< 0.0001
0.059
Mean
10.20 ± 1.05
9.71 ± 0.86
9.10 ± 0.78
Mean Ranks
69.81
49.34
32.27
Kt/v
N
24
54
22
< 0.0001
< 0.0001
< 0.0001
< 0.0001
Mean Ranks
88.50
49.50
11.50
P value is calculated by Kruskal-Wallis H test
Comparison between three groups is calculated by post-hoc test
Table 4
Analysis of the subscales of the questionnaire in the studied groups (n = 100)
Questionnaire’s items
Kt/V Groups
N
Mean Rank
P value*
 
P value**
Symptoms / problems list
Group-A
24
77.08
< 0.0001
Group-A vs Group-B
0.004
Group-B
54
54.57
Group-A vs Group-C
< 0.0001
Group-C
22
11.5
Group-B vs Group-C
< 0.0001
Effect of kidney disease
Group-A
24
81.9
< 0.0001
Group-A vs Group-B
< 0.0001
Group-B
54
52.31
Group-A vs Group-C
< 0.0001
Group-C
22
11.8
Group-B vs Group-C
< 0.0001
Burden of kidney disease
Group-A
24
71.94
< 0.0001
Group-A vs Group-B
0.095
Group-B
54
56.86
Group-A vs Group-C
< 0.0001
Group-C
22
11.5
Group-B vs Group-C
< 0.0001
Work Status
Group-A
24
44.25
0.003
Group-A vs Group-B
1.000
Group-B
54
46.61
Group-A vs Group-C
0.086
Group-C
22
66.86
Group-B vs Group-C
1.000
Cognitive Function
Group-A
24
70.19
< 0.0001
Group-A vs Group-B
0.122
Group-B
54
56.06
Group-A vs Group-C
< 0.0001
Group-C
22
15.39
Group-B vs Group-C
< 0.0001
Quality of Social interaction
Group-A
24
40.27
< 0.0001
Group-A vs Group-B
< 0.0001
Group-B
54
69.23
Group-A vs Group-C
0.011
Group-C
22
15.68
Group-B vs Group-C
< 0.0001
Sleep
Group-A
24
79.35
< 0.0001
Group-A vs Group-B
0.001
Group-B
54
53.56
Group-A vs Group-C
< 0.0001
Group-C
22
11.5
Group-B vs Group-C
< 0.0001
Overall Health
Group-A
24
69.88
< 0.0001
Group-A vs Group-B
0.222
Group-B
54
57.78
Group-A vs Group-C
< 0.0001
Group-C
22
11.5
Group-B vs Group-C
< 0.0001
1.1.Patient Satisfaction
Group-A
24
58.88
0.001
Group-A vs Group-B
0.021
Group-B
54
41.43
Group-A vs Group-C
1.000
Group-C
22
63.64
Group-B vs Group-C
0.003
Physical Function
Group-A
24
66.23
< 0.0001
Group-A vs Group-B
0.071
Group-B
54
57.45
Group-A vs Group-C
< 0.0001
Group-C
22
16.27
Group-B vs Group-C
< 0.0001
Role limitation due to Physical function
Group-A
24
56.96
0.39
Group-A vs Group-B
 
Group-B
54
50.55
Group-A vs Group-C
 
Group-C
22
43.34
Group-B vs Group-C
 
General Health
Group-A
24
75.79
< 0.0001
Group-A vs Group-B
< 0.0001
Group-B
54
37.89
Group-A vs Group-C
0.001
Group-C
22
53.86
Group-B vs Group-C
0.018
Pain
Group-A
24
74.75
< 0.0001
Group-A vs Group-B
0.011
Group-B
54
55.45
Group-A vs Group-C
< 0.0001
Group-C
22
11.6
Group-B vs Group-C
< 0.0001
Emotional Well Being
Group-A
24
70.92
0.001
Group-A vs Group-B
0.171
Group-B
54
57.31
Group-A vs Group-C
< 0.0001
Group-C
22
11.5
Group-B vs Group-C
< 0.0001
1.1.Role limitations due to emotional function
Group-A
24
64.88
0.26
Group-A vs Group-B
 
Group-B
54
53.96
Group-A vs Group-C
 
Group-C
22
26.32
Group-B vs Group-C
 
Social Functions
Group-A
24
80.35
< 0.0001
Group-A vs Group-B
< 0.0001
Group-B
54
52.58
Group-A vs Group-C
< 0.0001
Group-C
22
12.82
Group-B vs Group-C
< 0.0001
Energy
Group-A
24
74.5
< 0.0001
Group-A vs Group-B
0.042
Group-B
54
55.72
Group-A vs Group-C
< 0.0001
Group-C
22
11.5
Group-B vs Group-C
< 0.0001
Physical Composite
Group-A
24
65.92
0.002
Group-A vs Group-B
0.042
Group-B
54
51.33
Group-A vs Group-C
0.001
Group-C
22
31.64
Group-B vs Group-C
0.129
Mental Composite
Group-A
24
70.54
< 0.0001
Group-A vs Group-B
0.149
Group-B
54
57.31
Group-A vs Group-C
< 0.0001
Group-C
22
11.91
Group-B vs Group-C
< 0.0001
*P value is calculated by Kruskal-Wallis H test
**P value is calculated by Bonferroni post-hoc test
A significant difference was found regarding pre-session weight and interdialytic weight gain after improvement of kt/v in group C. (Table 5). There was a statistically significant difference regarding both dialysis session duration and PTH; with lower PTH values and longer dialysis sessions duration in patients with improved Kt/v (Table 6). Post dialysis urea, phosphorous and hemoglobin were significantly changed in group C after improvement of kt/v (Table 7).
Table 5
Comparison between patient general data of group C before and after improvement of kt/v
 
N
Mean ± SD
Median (IQR)
*p value
Pre-session weight (kg)
Before
22
79.09 ± 13.99
79.00 (66.75–87.25)
0.031
After
78.77 ± 14.02
79.00 (66.50–87.25)
Post-session weight (kg)
Before
22
75.82 ± 13.91
76.00 (64.00–85.00))
0.104
After
75.91 ± 13.99
76.00 (64.00–85.37)
Interdialytic weight gain (Kg)
Before
22
3.21 ± 0.59
3.00 (3.00–4.00)
0.025
After
2.86 ± 0.58
3.00 (2.5–3.00)
*P value is calculated by paired t test
Table 6
Paired comparison of dialysis duration and parathyroid hormone in group C before and after improvement of kt/v
 
N
Median (IQR)
*P value
Before
After
Dialysis session duration (hrs)
22
3.00 (3–3)
4.00
< 0.001
PTH (pg/dl) #
22
784.50 (343.50–979.50)
632.00(343.50–873.75)
0.002
*P value was computed by Wilcoxon Signed Ranks test
Table 7
comparison between patient laboratory data of group C before and after improvement of kt/v:(n = 22)
 
N
Mean ± SD
Median (IQR)
p value*
Pre-session Urea (mg/dl)
Before
22
129.0 ± 35.17
128.50 (98.75–156.00)
0.668
After
132.00 ± 20.43
133.00 (121.25–147.00)
Post-session Urea (mg/dl)
Before
22
56.36 ± 17.32
59.50 (40.00–68.50)
0.001
After
43.73 ± 6.73
46.50 (39.75–48.25)
Serum calcium (mg/dl)
Before
22
8.93 ± 0.88
9.00 (8.33–9.45)
0.322
After
8.75 ± 0.79
8.9 (8.03–9.43)
Serum phosphorus (mg/dl)
Before
22
5.37 ± 0.75
5.40 (4.88–6.03)
< 0001
After
22
4.06 ± 0.59
4.00 (3.75–4.50)
Serum albumin (g/dl)
Before
22
3.28 ± 0.46
3.20 (2.98–3.50)
0.329
After
3.23 ± 0.49
3.15 (2.88–3.43)
Hemoglobin (g/dl)
Before
22
9.17 ± 0.78
9.10 (8.50–9.73)
< 0001
After
10.90 ± 0.88
10.00 (9.50–10.80)
Kt/v
Before
22
0.99 ± 0.12
1.03 (0.96–1.08)
< 0001
After
1.31 ± 0.06
1.32 (1.25–1.35)
*P value is calculated by paired t test
All the studied subscales showed significant change after improvement of kt/v except for Work status, Patient satisfaction, Role limitation for physical and Role limitation due to emotional problems (Table 8).
Table 8
Analysis of the subscales of the questionnaire in group C before and after improvement of kt/v
Subscales of the questionnaire
N
Median(IQR)
P value*
Before
After
Symptoms / problems list
22
39.58 (35.42–45.33)
71.88 (41.67–79.17)
< 0.001
Effect of kidney disease
22
50.00 (46.09–53.13)
59.38 (50.00–68.75)
0.003
Burden of kidney disease
22
31.25 (25.00–31.25)
50.00 (31.25–62.50)
0.001
Work status
22
50.00 (50.00–50.00)
50.00 (0.00–50.00)
0.248
Cognitive function
22
73.33 (66.67–73.33)
80.00 (71.67–86.67)
0.003
Quality of social interaction
22
46.67 (38.33–53.33)
66.67 (40.00–73.33)
0.002
Sleep
22
35.00 (27.50–40.63)
62.50 (38.13–70.00)
0.001
Overall health
22
30.00 (20–30)
70.00 (30.00–70.00)
0.001
Patient satisfaction
22
50.00 (45.83–54.17)
41.66 (33.33–50.00)
0.115
Physical function
22
32.50 (25.00–35.00)
45.00 (33.75–55.00)
0.002
Role limitation due to physical function
22
10.00 (0.00–50.00)
25.00 (25.00–50.00)
0.415
General health
22
55.00 (45.00–11.25)
47.50 (40.00–55.00)
0.060
Pain
22
12.50 (10.00–22.50)
45.00(20.00–55.63)
0.001
Emotion well-Being
22
38.00 (32.00–44.00)
60.00 (40.00–68.00)
0.001
Role limitations due to emotional problems
22
33.33 (0.00–33.33)
33.33 (25.00–66.67)
0.194
Social function
22
25.00 (12.50–37.50)
50.00 (25.00–62.5.00)
0.002
Energy
22
25.00 (20.00–26.50)
45.00 (23.75–55.00)
0.001
Physical composite
22
32.49 (29.30–36.90)
36.55 (33.99–41.22)
0.042
Mental composite
22
28.05 (24.66–32.21)
35.40 (27.49–46.86)
0.002
*P value was computed by by Wilcoxon Signed Ranks test
Regarding linear study of Kt/v and the summarizing domains of SF-36 (physical and mental composites), the correlation of Kt/v and these domains controlled for two important correlated confounders, namely Hemoglobin and PTH showed statistically significant positive correlation. When Work status was correlated to Kt/v (controlled also to PTH, hemoglobin), it didn’t show any significance (r = − 0.168, p = 0.068) (Table 9).
Table 9
Partial correlation of Kt/v with some subscales of KDQOL-SF™ questionnaire (Control variables are PTH, hemoglobin)
 
Work status
Physical composite
Mental composite
Kt/v r
−0.168
0.304
0.587
p
0.068
0.002
< 0.0001

Discussion

ESRD is an important problem gradually increasing worldwide [1]. It has a considerable impact on the functional status and quality of life (QOL) perceived by the patient. Even in relatively early stages of chronic kidney disease, it may be mainly due to accumulation of uremic toxins which result in uremic symptoms such as dry skin, sleep difficulty, itching, numbness/tingling, decreased interest in sex, and bone/joint pain which may interrupt daily-life activities of patients [19]. HD is the most commonly used treatment option for this stage [2] a method that removes large amounts of uremic toxins with expected improvement of quality of life. However, hemodialysis, in itself, can lead to significant changes in patients’ lifestyle and may possibly impair its quality [3]. This may be due to hemodialysis related complications as muscle cramps, pruritus, anorexia and access problems.
The kidney Disease Outcomes Quality Initiative (K/DOQI) recommended monitoring the Health Related Quality of Life (HRQOL) for all patients with renal disease [20]. Although there are several standard questionnaires available for assessment of quality of life, the KDQOL-SF is the most commonly used one. It has many advantages compared to other instruments; it has been tested in several populations with kidney disease, has both general and specific modules to assess chronic kidney disease, can be used both for patients on HD and peritoneal dialysis, has questions about the sexual area, and can be self-applied or applied by an interviewer [13]. In a multitude of research, a strong correlation between HD dose and clinical outcomes has been described, and dialysis adequacy is now considered a strong predictor for morbidity and mortality of ESRD patients treated with regular hemodialysis [21]. Dialysis adequacy and optimal dosing can be assessed utilizing several techniques and methods; among which, the Kt/v determined by single pool urea kinetic modeling, is the most frequently used and preferred method for the numerical expression of dialysis dose and or adequacy, as it is more specific and accurate [22]. A minimum Kt/V units per dialysis session of 1.2, carried out 3 times per week, has been recommended as an acceptable target; a recommendation that was essentially advocated by the well-conducted HEMO study [23].
In Egypt, especially in our locality, many physicians looking after hemodialysis patients are interested mainly in the clinical and laboratory data of their patients, paying little attention to the patients’ emotional satisfaction and their quality of life. The present study was planned with a main focus of assessment of HRQOL among ESRD patients treated with hemodialysis in relation to different variables, especially the adequacy of dialysis relying on the calculated kt/V.
So, this work was carried out on 100 ESRD patients (51% males; with mean age of 48 ± 5.89), maintained on regular hemodialysis three times weekly. Dialysis adequacy was assessed by single pool Kt/V, and KDQOL-SF questionnaire was utilized for determining the quality of life. Taking KDIGO (2012) guidelines for anemia in ESRD in consideration, nearly half of patients in the current study fulfilled the target hemoglobin [24], while 45% of the patients were within the recommended standard levels of serum calcium according to KDIGO (2009) guidelines and one fifth suffered from low serum calcium [25]. Regarding serum phosphorus, utilizing the recommended values of KDIGO guidelines, nearly a quarter of the patients had hyperphosphatemia, while hypophosphatemia was encountered less frequent. On the other hand, more than one third of the patients had hyperparathyroidism by the previous reference criteria. Hypoalbuminemia afflicted many patients in the present study; this might be due to anorexia, malnutrition and inflammation which are common findings in HD patients [26, 27].
The baseline Kt/v of the majority of patients in the current study, with a mean value of 1.4, was within the target recommendation by the National kidney foundation Disease Outcomes Quality Initiative [20]clinical practice guidelines, > 1.2, which reflects a reasonable patient care service. However, recent guidelines recommended higher value > 1.4 which reflect more interest of the international community in improving the dose of dialysis that could have positive impacts on patients quality of life [28].
The physical domain includes three subscales; namely, physical function, role limitation due to physical function, and bodily pain. In previous studies this domain was reported to be a significantly associated predictor of both death and hospitalization [29, 30]. This argues for the importance of improving the physical component in hemodialysis patients; a change that is expected to effectively decrease the risk of death and recurrent hospitalization for these patients with less cost on the community [30].
In the current study each of the three subscales of the physical domain had a score of below an average of 50, suggesting that these patients are suffering from poor physical performance. This is in agreement with the corresponding findings reported for the European and American patients in DOPPS study [31]. However, in the latter study the Japanese patients had a score which was above the previously mentioned average, which are thought to reflect their better awareness of the clinical problems and possibly denoting better health education conducted by their caring staff.
Many studies have proposed several points for improving the component of the physical domain. Physical exercise has been the focus of interest in a good body of literature [3234]. In a systematic review of 29 clinical trials, improvement of the physical condition following the use of aerobic training was observed [35]. The importance of physical exercise not only has a valuable effect on the physical component of QOL, but also improves cardiopulmonary fitness, anemia, hyperlipidemia, chronic inflammation, blood pressure, insulin resistance, anxiety, depression and adequacy of dialysis [36, 37]. Although the physical exercise in hemodialysis patients has many beneficial effects and it should be mandatory not optional for patients with ESRD, exercise programs are still not a part of routine clinical practice in many countries [38].
On the other hand, the mental domain includes social function, role limitation due to mental function and general mental health. The first two subscales, in the present study, scored above 50 while the third one (mental health) approached 100 which represents the maximum score for this subscale. These findings are in accordance with the corresponding findings of Czyzewski.​et.​al., 2014 and the DOPPS study [17, 30]. The mental status of the hemodialysis patients is intimately linked to the social status which is expected to be badly changed by their illness and inability to work and get suitable financial coverage. These patients might consequently lose their self-esteem and feel handicapped. Moreover, hemodialysis itself may cause mood and sleep disorders which would result in more mental suffering, imposing much burden on the caring nephrologists and dialysis staff.
Important points to improve mental status should include training of patients to talk with their doctors whenever they feel down, anxious, worried, nervous or fearful. This may help to assess their problems and start to plan for solutions. Group therapy is another successful way that can improve mental health as not only has a self-confidence effect, but also it enables the patients to feel that they are not alone in their struggle with dialysis [39]. Other ways of intervention may include using antidepressant drugs which should be prescribed in the proper modified doses by caring physicians [40]. More ideas in this respect may comprise utilizing entertainment tools in dialysis wards, such as televisions, radio and magazines, recreational group outings, and frequently improving the decoration of dialysis rooms.
In addition to the above-mentioned subscales within the mental and physical domains, two other subscales, namely, energy and general health perception are expected to be reflected on both of them. In the current study, both energy and general health perception showed an average or even below average scores; findings that are in parallel with those reported in a study by Merkus and colleagues, 2017 [41].
Kt/v, determined by single pool urea kinetic modeling, is the most frequently used and preferred method for the numerical expression of dialysis dose and or adequacy, as it is more specific and accurate [42]. In the current study Kt/V was utilized to divide the patients into three groups of highly adequate, intermediately adequate and inadequate, for the purpose of analytical comparisons, relying on a Kt/V cut points of 1.2 and 1.5. A similar way of subdividing the patients relying on cut-off values of Kt/V was also adopted by many previous groups of researches. Akhil Babu et al. [43], divided his studied patients into two groups of adequate and inadequate dialysis efficiency, utilizing a Kt/V value of 1.4 as a separator. While two other studies [44, 45] divided their patients according to a Kt/V of < 1.2 and ≥ 1.2.
In the present work, the group with highest Kt/V was noticed to have a mean dry weight which is higher than that of the other two groups; an explanation of that may be related to their better dialysis adequacy leading to lower GIT problems, better appetite, lower inflammation and higher anabolism [46]. However, following improvement of the dialysis adequacy for 3 months, the mean dry weight did not show significant changes. Lack of putting on weight in this situation could probably reflect insufficient period of observation; had they been given more time with the better Kt/V could have been translated into better body building and more weight gain.
Adequacy of dialysis is related to many factors; for example, duration and frequency of dialysis sessions, dialyzer size and its characteristics, dialysate and blood flow rates, and nature of vascular accesses and whether or not blood recirculation existed [47]. In the current study, the group of poorest dialysis adequacy was noticed to ask for termination of their sessions ahead of time. This non- compliance in sticking to the proper session duration was usually also associated with low compliance regarding diet, salt and water intake, which could be an explanation for their higher interdialytic weight gain in this particular group in comparison to the other two groups. Consequently, increasing the duration of sessions was utilized to improve the dialysis adequacy in this group. Alongside with the significant increase in session duration, there was significant consequent decrease in the interdialytic weight gain.
Having appreciated the positive impact of improving dialysis adequacy on many clinical and biochemical data of patients [6, 48], one would expect welcome effects on the quality of life. In the present research, the quality of life variables were compared among the three groups. These variables were also compared before and after improving dialysis adequacy in group C. All the subscales of the physical domain, except role limitations due to physical function impairment, were found to be significantly low in group C. These low scores were parallel to results reported in similar studies [49, 50]. Work status was significantly higher in group C (p = 0.003 but post hoc analysis didn’t show significance between groups). When Work status was correlated to Kt/v (controlled to PTH, hemoglobin), it didn’t show any significance (r = − 0.168, p = 0.068). We were not astonished by this non- significant correlation as this subscale was already higher (better) in group C (lowest Kt/v) than the other 2 groups and improving Kt/v wouldn’t render a significant change in this group.
The physical domain subscales, apart from the subscales concerning the general health, role limitations due to physical function impairment and work status, were improved after improving of Kt/V. This improvement in the majority of subscales of the physical domain was associated with improvement in the physical composite score by 12.5%; as this latter score is calculated from all of the above mentioned subscales.
Likewise, all the subscales of the mental and kidney domains were significantly lower in the same group of poorest adequacy; findings confirming previously published data [49, 50], some of these subscales did not even show improvement after ameliorating the dialysis adequacy. It is worthwhile to note that the improvement in the mental health composite was two-fold higher than that in the physical health composite. This preferential improvement may possibly be ascribed to repeated patient-doctor interactions during the study which could raise the interest in the concept of quality of life among the patients. This might promote the doctors to pay more attention towards their patients’ psychological aspect during reassessment of the KDQol-SF.
One possible explanation for lack of improvement of some subscales after enhancement of the dialysis dose, in spite of the fact that they were better in group A (Kt/v > 1.5), could be their possible need for more time to achieve their fully expressed response.
Many previous studies examined the association between adequacy of dialysis mostly using Kt/V and the HRQOL; some showed no significant association but others showed dissimilar results [4, 41, 51]. These results are in contrast with the result in the current study; differences might be due to the small size sample [51], collection of data just after 3 months from the start of dialysis – a time when residual renal function may still be present and a duration that may be too short to have an effect on the quality of life [41]. Another difference could be using urea reduction rate as a single assessment tool for adequacy of dialysis [4].
The present study has the merit of comparing three groups of patients based on kt/v, one of them above the target and another below the lower target of 1.2, which allowed scrutiny the effects of kt/ v on different subscales of Qol. Another good point is the paired comparisons of the Qol variables before and after enhancing dialysis adequacy which could envision the benefits of improving the kt/v on the patients’ perception of their Qol.
Having said that, the present research has got some limitations; firstly, the duration of follow up after improvement of kt / v was limited to 3 month – a duration that might not permit full expression of improvement of the quality of life especially in the physical aspect. Secondly, the present study has relied on single measurements of kt/v which might not be as accurate indicator of dialysis adequacy as multiple measurements of the same tool over the whole period of observation.

Conclusion

One would suggest that hemodialysis service providers should have a continuous quality of life assessment plan and make corrective actions when necessary to improve it. Detection and improvement of suboptimal dialysis adequacy is one important point in this aspect as this would have a welcome effect on patients’ capabilities as productive members of community.

Acknowledgments

The authors acknowledge the great efforts and contributions of all staff members of MNDU and all participants in this study since without them, this study would have never been accomplished.

Disclosure

This work was not funded.

Declarations

Ethical approval

The study was approved by the institutional research board (IRB) of Faculty of Medicine, Mansoura University in accordance with the Declaration of Helsinki. All participants signed a written informed consent before the start of the study.
Not applicable.

Competing interests

All the authors declare no conflict of interest in this work.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.PubMedPubMedCentralCrossRef Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Makusidi M, Liman H, Yakubu A, Isah M, Abdullahi S, Chijioke A. Hemodialysis performance and outcomes among end stage renal disease patients from Sokoto, North-Western Nigeria. Indian J Nephrol. 2014;24(2):82.PubMedPubMedCentralCrossRef Makusidi M, Liman H, Yakubu A, Isah M, Abdullahi S, Chijioke A. Hemodialysis performance and outcomes among end stage renal disease patients from Sokoto, North-Western Nigeria. Indian J Nephrol. 2014;24(2):82.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Sultania P, Sharma SK, Sharma S. Adequacy of hemodialysis in Nepalese patients undergoing maintenance hemodialysis. J Nepal Med Assoc. 2009;48(173). Sultania P, Sharma SK, Sharma S. Adequacy of hemodialysis in Nepalese patients undergoing maintenance hemodialysis. J Nepal Med Assoc. 2009;48(173).
4.
Zurück zum Zitat Ayoub A, Hijjazi K. Quality of life in dialysis patients from the United Arab Emirates. J Fam Community Med. 2013;20(2):106.CrossRef Ayoub A, Hijjazi K. Quality of life in dialysis patients from the United Arab Emirates. J Fam Community Med. 2013;20(2):106.CrossRef
5.
Zurück zum Zitat Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996;50(2):550–6.PubMedCrossRef Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996;50(2):550–6.PubMedCrossRef
6.
Zurück zum Zitat Barril G, Besada E, Caro P, et al. News and traditional indications from short daily dialysis: different schemes to optimized ESF response. Hemodial Int. 2004;8(1):85.CrossRef Barril G, Besada E, Caro P, et al. News and traditional indications from short daily dialysis: different schemes to optimized ESF response. Hemodial Int. 2004;8(1):85.CrossRef
7.
Zurück zum Zitat Johansen KL, Chertow GM, Ng AV, et al. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int. 2000;57(6):2564–70.PubMedCrossRef Johansen KL, Chertow GM, Ng AV, et al. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int. 2000;57(6):2564–70.PubMedCrossRef
8.
Zurück zum Zitat Kimmel PL, Patel SS. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol. 2006:68–79 Elsevier. Kimmel PL, Patel SS. Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol. 2006:68–79 Elsevier.
9.
Zurück zum Zitat Bethesda MD. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2017. Bethesda MD. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2017.
10.
Zurück zum Zitat Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manag. 2005;30(5):465–73.CrossRef Davison SN, Jhangri GS. The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients. J Pain Symptom Manag. 2005;30(5):465–73.CrossRef
11.
Zurück zum Zitat Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4(8):1293–301.PubMedPubMedCentralCrossRef Mujais SK, Story K, Brouillette J, et al. Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4(8):1293–301.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOLTM) instrument. Qual Life Res. 1994;3(5):329–38.PubMedCrossRef Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOLTM) instrument. Qual Life Res. 1994;3(5):329–38.PubMedCrossRef
13.
Zurück zum Zitat Hays RD, Kallich JD, Mapes DL, et al. Kidney disease quality of life short form (KDQOL-SF), version 1.3: a manual for use and scoring, vol. 39. Santa Monica: Rand; 1997. Hays RD, Kallich JD, Mapes DL, et al. Kidney disease quality of life short form (KDQOL-SF), version 1.3: a manual for use and scoring, vol. 39. Santa Monica: Rand; 1997.
14.
Zurück zum Zitat Daugirdas JT, Depner TA, Gotch FA, et al. Comparison of methods to predict equilibrated Kt/V in the HEMO pilot study. Kidney Int. 1997;52(5):1395–405.PubMedCrossRef Daugirdas JT, Depner TA, Gotch FA, et al. Comparison of methods to predict equilibrated Kt/V in the HEMO pilot study. Kidney Int. 1997;52(5):1395–405.PubMedCrossRef
15.
Zurück zum Zitat Korevaar JC, Merkus MP, Jansen MAM, Dekker FW, Boeschoten EW, Krediet RT. Qual Life Res. 2002;11(5):437–47.PubMedCrossRef Korevaar JC, Merkus MP, Jansen MAM, Dekker FW, Boeschoten EW, Krediet RT. Qual Life Res. 2002;11(5):437–47.PubMedCrossRef
16.
Zurück zum Zitat Ware JE, Keller SD, Kosinski M. SF-36 physical and mental health summary scales: Health Assessment Lab Boston; 1994. Ware JE, Keller SD, Kosinski M. SF-36 physical and mental health summary scales: Health Assessment Lab Boston; 1994.
17.
Zurück zum Zitat Czyżewski L, Sańko-Resmer J, Wyzgał J, Kurowski A. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant. 2014;19:576–85.PubMedCrossRef Czyżewski L, Sańko-Resmer J, Wyzgał J, Kurowski A. Assessment of health-related quality of life of patients after kidney transplantation in comparison with hemodialysis and peritoneal dialysis. Ann Transplant. 2014;19:576–85.PubMedCrossRef
18.
Zurück zum Zitat ElHafeez SA, Sallam SA, Gad ZM, Zoccali C, Torino C, Tripepi G, et al. Cultural adaptation and validation of the “kidney disease and quality of life-short form (KDQOL-SF™) version 1.3” questionnaire in Egypt. BMC Nephrol. 2012;13(1):170.CrossRef ElHafeez SA, Sallam SA, Gad ZM, Zoccali C, Torino C, Tripepi G, et al. Cultural adaptation and validation of the “kidney disease and quality of life-short form (KDQOL-SF™) version 1.3” questionnaire in Egypt. BMC Nephrol. 2012;13(1):170.CrossRef
19.
Zurück zum Zitat Danquah FVN, Zimmerman L, Diamond PM, Meininger J, Bergstrom N. Frequency, severity, and distress of dialysis-related symptoms reported by patients on hemodialysis. Nephrol Nurs J. 2010;37(6):627–39.PubMed Danquah FVN, Zimmerman L, Diamond PM, Meininger J, Bergstrom N. Frequency, severity, and distress of dialysis-related symptoms reported by patients on hemodialysis. Nephrol Nurs J. 2010;37(6):627–39.PubMed
20.
Zurück zum Zitat KDOQI. Clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis. 2006;48(1):1–322. KDOQI. Clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy and vascular access. Am J Kidney Dis. 2006;48(1):1–322.
21.
Zurück zum Zitat Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002;13(4):1061–6.PubMedCrossRef Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA. Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol. 2002;13(4):1061–6.PubMedCrossRef
22.
Zurück zum Zitat Brenner B, Taal M, Chertow G, Marsden P, Skorecki K, Yu A. Brenner and Rector's the kidney E-book; 2011. p. 2314–8. Brenner B, Taal M, Chertow G, Marsden P, Skorecki K, Yu A. Brenner and Rector's the kidney E-book; 2011. p. 2314–8.
23.
Zurück zum Zitat Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–9.PubMedCrossRef Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–9.PubMedCrossRef
24.
Zurück zum Zitat KDIGO. Clinical practice guideline for anemia in chronic kidney disease. Kidney Int. 2012;2:279. KDIGO. Clinical practice guideline for anemia in chronic kidney disease. Kidney Int. 2012;2:279.
25.
Zurück zum Zitat KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(113):1–130. KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(113):1–130.
26.
Zurück zum Zitat Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis. 2003;42(2):286–94.PubMedCrossRef Danielski M, Ikizler TA, McMonagle E, Kane JC, Pupim L, Morrow J, et al. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis. 2003;42(2):286–94.PubMedCrossRef
27.
Zurück zum Zitat Sridhar NR, Josyula S. Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships-a 2 year single center study. BMC Nephrol. 2013;14(1):242.PubMedPubMedCentralCrossRef Sridhar NR, Josyula S. Hypoalbuminemia in hemodialyzed end stage renal disease patients: risk factors and relationships-a 2 year single center study. BMC Nephrol. 2013;14(1):242.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, et al. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884–930.CrossRef Daugirdas JT, Depner TA, Inrig J, Mehrotra R, Rocco MV, Suri RS, et al. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am J Kidney Dis. 2015;66(5):884–930.CrossRef
29.
Zurück zum Zitat DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30(2):204–12.PubMedCrossRef DeOreo PB. Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. Am J Kidney Dis. 1997;30(2):204–12.PubMedCrossRef
30.
Zurück zum Zitat Mapes DL, Bragg-Gresham JL, Bommer J, Fukuhara S, McKevitt P, Wikström B, et al. Health-related quality of life in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004;44:54–60.PubMedCrossRef Mapes DL, Bragg-Gresham JL, Bommer J, Fukuhara S, McKevitt P, Wikström B, et al. Health-related quality of life in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004;44:54–60.PubMedCrossRef
31.
Zurück zum Zitat Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA. The Dialysis outcomes and practice patterns study (DOPPS): design, data elements, and methodology. Am J Kidney Dis. 2004;44:7–15.PubMedCrossRef Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA. The Dialysis outcomes and practice patterns study (DOPPS): design, data elements, and methodology. Am J Kidney Dis. 2004;44:7–15.PubMedCrossRef
32.
Zurück zum Zitat Johansen KL. Exercise in the end-stage renal disease population. J Am Soc Nephrol. 2007;18(6):1845–54.PubMedCrossRef Johansen KL. Exercise in the end-stage renal disease population. J Am Soc Nephrol. 2007;18(6):1845–54.PubMedCrossRef
33.
Zurück zum Zitat Kosmadakis GC, Bevington A, Smith A, Clapp E, Viana J, Bishop N, et al. Physical exercise in patients with severe kidney disease. Nephron Clin Pract. 2010;115(1):c7–c16.PubMedCrossRef Kosmadakis GC, Bevington A, Smith A, Clapp E, Viana J, Bishop N, et al. Physical exercise in patients with severe kidney disease. Nephron Clin Pract. 2010;115(1):c7–c16.PubMedCrossRef
34.
Zurück zum Zitat Liu Y-M, Yeh M-L, Chung Y-C. Improving physiological and psychological status in a hemodialysis patient: a nursing experience using an exercise training program. Hu Li Za Zhi. 2013;60(5):104.PubMed Liu Y-M, Yeh M-L, Chung Y-C. Improving physiological and psychological status in a hemodialysis patient: a nursing experience using an exercise training program. Hu Li Za Zhi. 2013;60(5):104.PubMed
35.
Zurück zum Zitat Cheema BSB, Fiatarone Singh MA. Exercise training in patients receiving maintenance hemodialysis: a systematic review of clinical trials. Am J Nephrol. 2005;25(4):352–64.PubMedCrossRef Cheema BSB, Fiatarone Singh MA. Exercise training in patients receiving maintenance hemodialysis: a systematic review of clinical trials. Am J Nephrol. 2005;25(4):352–64.PubMedCrossRef
36.
Zurück zum Zitat Miller BW, Cress CL, Johnson ME, Nichols DH, Schnitzler MA. Exercise during hemodialysis decreases the use of antihypertensive medications. Am J Kidney Dis. 2002;39(4):828–33.PubMedCrossRef Miller BW, Cress CL, Johnson ME, Nichols DH, Schnitzler MA. Exercise during hemodialysis decreases the use of antihypertensive medications. Am J Kidney Dis. 2002;39(4):828–33.PubMedCrossRef
37.
Zurück zum Zitat Painter P. Physical functioning in end-stage renal disease patients: update 2005. Hemodial Int. 2005;9(3):218–35.PubMedCrossRef Painter P. Physical functioning in end-stage renal disease patients: update 2005. Hemodial Int. 2005;9(3):218–35.PubMedCrossRef
40.
Zurück zum Zitat Hedayati SS, Yalamanchili V, Finkelstein FO. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 2012;81(3):247–55.PubMedCrossRef Hedayati SS, Yalamanchili V, Finkelstein FO. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 2012;81(3):247–55.PubMedCrossRef
41.
Zurück zum Zitat Merkus MP, Jager KJ, Dekker FW, et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis. 1997;29(4):584–92.PubMedCrossRef Merkus MP, Jager KJ, Dekker FW, et al. Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. Am J Kidney Dis. 1997;29(4):584–92.PubMedCrossRef
42.
Zurück zum Zitat Kuhlmann MK, Kotanko P, Levin NW. Haemodialysis: Dialysis prescription and adequacy. In: Feehally J et al's comprehensive clinical nephrology sixth edition, vol. 1082. Edinburgh London new York; 2019. p. 1089. Kuhlmann MK, Kotanko P, Levin NW. Haemodialysis: Dialysis prescription and adequacy. In: Feehally J et al's comprehensive clinical nephrology sixth edition, vol. 1082. Edinburgh London new York; 2019. p. 1089.
43.
Zurück zum Zitat Babu A, Singh J, Ganesh N. A study on adequacy of hemodialysis and quality of life in Esrd patients OSR. J Pharm Biol Sci (IOSR-JPBS). 2018;18:24–30. Babu A, Singh J, Ganesh N. A study on adequacy of hemodialysis and quality of life in Esrd patients OSR. J Pharm Biol Sci (IOSR-JPBS). 2018;18:24–30.
44.
Zurück zum Zitat Chen JB, Lam KK, Su YJ, et al. Relationship between Kt/V urea-based dialysis 9/1adequacy and nutritional status and their effect on the components of the quality of life in incident peritoneal dialysis patients. BMC Nephrol. 2012;13(1):39.PubMedPubMedCentralCrossRef Chen JB, Lam KK, Su YJ, et al. Relationship between Kt/V urea-based dialysis 9/1adequacy and nutritional status and their effect on the components of the quality of life in incident peritoneal dialysis patients. BMC Nephrol. 2012;13(1):39.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat El-Sheikh M, El-Ghazaly G. Assessment of hemodialysis adequacy in patients with chronic kidney disease in the hemodialysis unit at Tanta University Hospital in Egypt. Indian J Nephrol. 2016;26(6):398.PubMedPubMedCentralCrossRef El-Sheikh M, El-Ghazaly G. Assessment of hemodialysis adequacy in patients with chronic kidney disease in the hemodialysis unit at Tanta University Hospital in Egypt. Indian J Nephrol. 2016;26(6):398.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Stolic R, Trajkovic G, Jovanovic A, et al. Carotid ultrasonographic parameters as markers of atherogenesis and mortality rate in patients on hemodialysis. Vojnosanit Pregl. 2010;67(11):916–22.PubMedCrossRef Stolic R, Trajkovic G, Jovanovic A, et al. Carotid ultrasonographic parameters as markers of atherogenesis and mortality rate in patients on hemodialysis. Vojnosanit Pregl. 2010;67(11):916–22.PubMedCrossRef
47.
Zurück zum Zitat Locatelli F, Buoncristiani U, Canaud B, Kohler H, Petitclerc T, Zucchelli P. Haemodialysis with on-line monitoring equipment: tools or toys? Nephrol Dial Transplant. 2005;20(1):22–33.PubMedCrossRef Locatelli F, Buoncristiani U, Canaud B, Kohler H, Petitclerc T, Zucchelli P. Haemodialysis with on-line monitoring equipment: tools or toys? Nephrol Dial Transplant. 2005;20(1):22–33.PubMedCrossRef
48.
Zurück zum Zitat Cigarran S, Coronel F, Torrente J, Sevilla M, Baylón J. Risk of inadequate Dialysis dose in hemodialysis patients with high Watson volume. A warning. Hemodial Int. 2004a;8(1):84.CrossRef Cigarran S, Coronel F, Torrente J, Sevilla M, Baylón J. Risk of inadequate Dialysis dose in hemodialysis patients with high Watson volume. A warning. Hemodial Int. 2004a;8(1):84.CrossRef
49.
Zurück zum Zitat Manns BJ, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C. Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J. 2002;48(5):565–9.PubMedCrossRef Manns BJ, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C. Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J. 2002;48(5):565–9.PubMedCrossRef
50.
Zurück zum Zitat Kalender N, Tosun N. Determination of the relationship between adequacy of dialysis and quality of life and self-care agency. J Clin Nurs. 2014;23(5–6):820–8.PubMedCrossRef Kalender N, Tosun N. Determination of the relationship between adequacy of dialysis and quality of life and self-care agency. J Clin Nurs. 2014;23(5–6):820–8.PubMedCrossRef
51.
Zurück zum Zitat Morton AR, Meers C, Singer MA, et al. Quantity of dialysis: quality of life--what is the relationship? ASAIO J (American Society for Artificial Internal Organs: 1992). 1996;42(5):M713–7.CrossRef Morton AR, Meers C, Singer MA, et al. Quantity of dialysis: quality of life--what is the relationship? ASAIO J (American Society for Artificial Internal Organs: 1992). 1996;42(5):M713–7.CrossRef
Metadaten
Titel
Is health-related quality of life associated with adequacy of hemodialysis in chronic kidney disease patients?
verfasst von
Lamia M. Hasan
Dina A. H. Shaheen
Ghada A. H. El Kannishy
Nagy A. H. Sayed-Ahmed
Ahmed M. Abd El Wahab
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Nephrology / Ausgabe 1/2021
Elektronische ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-021-02539-z

Weitere Artikel der Ausgabe 1/2021

BMC Nephrology 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.